Inventor · disambiguated record
Barry D. Quart
Also filed as: QUART BARRY · QUART BARRY D
19 granted patents·14 pending applications·194 citations·filing 2006–2019
94Inventor score
Files withARDEA BIOSCIENCES INC14QUART BARRY D9NAPO PHARMACEUTICALS INC3HERON THERAPEUTICS INC2MINER JEFFREY2
Top patents by PatentIndex Score
33 records- 0195US8084483B2Compounds and compositions and methods of useQUART BARRY D·Filed 2008·Granted Dec 27, 2011·33 cites·26 claims
- 0293US8067041B2Method for treatment of constipation-predominant irritable bowel syndromeQUART BARRY D·Filed 2009·Granted Nov 29, 2011·37 cites·9 claims
- 0391US8648116B2Derivatives of N-(arylamino) sulfonamides including polymorphs as inhibitors of MEK as well as compositions, methods of use and methods for preparing the sameVERNIER JEAN-MICHEL·Filed 2008·Granted Feb 11, 2014·24 cites·25 claims
- 0491US8546437B2Compounds and compositions and methods of useQUART BARRY D·Filed 2011·Granted Oct 1, 2013·12 cites·25 claims
- 0591US7556831B2Method for treatment of constipation-predominant irritable bowel syndromeNAPO PHARMACEUTICALS INC·Filed 2007·Granted Jul 7, 2009·22 cites·7 claims
- 0690US8357713B2Compounds and compositions and methods of useARDEA BIOSCIENCES INC·Filed 2011·Granted Jan 22, 2013·9 cites·12 claims
- 0790US8283369B2Compounds and compositions and methods of useQUART BARRY D·Filed 2011·Granted Oct 9, 2012·11 cites·50 claims
- 0889US8808742B2Compositions and methods for preparing and using sameQUART BARRY D·Filed 2009·Granted Aug 19, 2014·20 cites·28 claims
- 0987US9402827B2Treatment of goutMINER JEFFREY·Filed 2011·Granted Aug 2, 2016·13 cites·14 claims
- 1080US8852649B2Compositions and methods for treating or preventing inflammatory bowel disease, familial adenomatous polyposis and colon cancerQUART BARRY D·Filed 2007·Granted Oct 7, 2014·3 cites·6 claims
- 1178US8846113B2Method for treatment of diarrhea-predominant irritable bowel syndromeQUART BARRY·Filed 2011·Granted Sep 30, 2014·5 cites·5 claims
- 1276US9980938B2Method for treatment of diarrhea-predominant irritable bowel syndromeNAPO PHARMACEUTICALS INC·Filed 2014·Granted May 29, 2018·2 cites·18 claims
- 1375US10047050B23,4-di-substituted pyridine compound, methods of using and compositions comprising the sameARDEA BIOSCIENCES INC·Filed 2012·Granted Aug 14, 2018·2 cites·13 claims
- 1468US9216179B2Treatment of gout and hyperuricemiaMINER JEFFREY·Filed 2011·Granted Dec 22, 2015·1 cites·4 claims
- 1568US2019142805A1Novel Compounds and Compositions and Methods of UseARDEA BIOSCIENCES INC·Filed 2019·Application pending·0 cites
- 1665US10183012B2Compounds and compositions and methods of useARDEA BIOSCIENCES INC·Filed 2016·Granted Jan 22, 2019·0 cites·21 claims
- 1763US2014005136A1Novel compounds and compositions and methods of useARDEA BIOSCIENCES INC·Filed 2013·Application pending·0 cites
- 1862US2011244049A1Compositions comprising 4-(2-(5-bromo-4-(1-cyclopropylnaphthalen-4-yl)-4h-1,2,4-triazol-3-ylthio)acetamido)-3-chlorobenzoic acid and pharmaceutically acceptable salts thereof, and methods for preparing and using sameARDEA BIOSCIENCES INC·Filed 2009·Application pending·0 cites
- 1960US2016221970A1Novel compounds and compositions and methods of useARDEA BIOSCIENCES INC·Filed 2016·Application pending·0 cites
- 2060US2008249066A1Antiviral compounds and compositionsARDEA BIOSCIENCES INC·Filed 2008·Application pending·0 cites
- 2159US9987250B2Compositions and methods for treating or preventing inflammatory bowel disease, familial adenomatous polyposis and colon cancerNAPO PHARMACEUTICALS INC·Filed 2014·Granted Jun 5, 2018·0 cites·14 claims
- 2258US10570095B23,4-di-substituted pyridine compound, methods of using and compositions comprising the sameARDEA BIOSCIENCES INC·Filed 2018·Granted Feb 25, 2020·0 cites·20 claims
- 2358US2018161314A1Methods for Treating Hyperuricemia and Related DiseasesARDEA BIOSCIENCES INC·Filed 2018·Application pending·0 cites
- 2455US9138450B2Method for treatment of constipation-predominant irritable bowel syndromeQUART BARRY D·Filed 2011·Granted Sep 22, 2015·0 cites·13 claims
- 2555US2007254050A1Method for treatment of diarrhea-predominant irritable bowel syndromeQUART BARRY D·Filed 2006·Application pending·0 cites
- 2655US2019015392A1Treatment of Gout and HyperuricemiaARDEA BIOSCIENCES INC·Filed 2018·Application pending·0 cites
- 2754US2020078363A1Post-surgical pain treatmentHERON THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 2852US2019231688A1Method of administering emulsion formulations of an nk-1 receptor antagonistHERON THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 2947US2016143889A1Treatment of gout and hyperuricemiaARDEA BIOSCIENCES INC·Filed 2015·Application pending·0 cites
- 3046US9095581B2Combinations of MEK inhibitors and Raf kinase inhibitors and uses thereofMINER JEFFREY N·Filed 2010·Granted Aug 4, 2015·0 cites·14 claims
- 3145US2016271122A1Combinations of mek inhibitors and raf kinase inhibitors and uses thereofARDEA BIOSCIENCES INC·Filed 2015·Application pending·0 cites
- 3244US2016374993A1Treatment of goutARDEA BIOSCIENCES INC·Filed 2016·Application pending·0 cites
- 3344US2013296345A1Methods for treating hyperuricemia and related diseasesQUART BARRY D·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Barry D. Quart files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →